Inventor · disambiguated record
Steen Lisby
Also filed as: LISBY STEEN
5 granted patents·17 pending applications·84 citations·filing 2007–2023
82Inventor score
Top patents by PatentIndex Score
22 records- 0194US9040050B2Combination treatment of CD38-expressing tumorsVAN DE WINKEL JAN·Filed 2007·Granted May 26, 2015·39 cites·68 claims
- 0293US9492565B2Human antibody drug conjugates against tissue factorGENMAB AS·Filed 2015·Granted Nov 15, 2016·7 cites·16 claims
- 0392US9168314B2Human antibody drug conjugates against tissue factorSATIJN DAVID·Filed 2011·Granted Oct 27, 2015·29 cites·11 claims
- 0486US2024294661A1Human antibody drug conjugates against tissue factorGENMAB AS·Filed 2023·Application pending·0 cites
- 0582US2024165226A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2023·Application pending·0 cites
- 0680US9540433B2Human antibodies and antibody-drug conjugates against CD74VERPLOEGEN SANDRA·Filed 2012·Granted Jan 10, 2017·6 cites·43 claims
- 0774US2021395384A1Human antibody drug conjugates against tissue factorGENMAB AS·Filed 2021·Application pending·0 cites
- 0873US2020114000A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2019·Application pending·0 cites
- 0972US2015231235A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2014·Application pending·0 cites
- 1071US9428582B2Method of treating rash in patients undergoing anti-EGFR therapyEDVARDSEN KLAUS·Filed 2007·Granted Aug 30, 2016·3 cites·34 claims
- 1169US2022323582A1Human antibodies and antibody-drug conjugates against cd74GENMAB AS·Filed 2021·Application pending·0 cites
- 1266US2019315880A1Human antibody drug conjugates against tissue factorGENMAB AS·Filed 2019·Application pending·0 cites
- 1366US2024252673A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2023·Application pending·0 cites
- 1465US2017136130A1Human antibody drug conjugates against tissue factorGENMAB AS·Filed 2016·Application pending·0 cites
- 1564US2022265844A1Dosing regimens for anti-tf-antibody drug-conjugatesGENMAB AS·Filed 2021·Application pending·0 cites
- 1660US2025041410A1Formulations Comprising a SADA ComplexY MABS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1760US2025051478A1scFv and Antibodies with Reduced MultimerisationY MABS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1851US2019030178A1Dosing regimens for anti-tf-antibody drug-conjugatesGENMAB AS·Filed 2016·Application pending·0 cites
- 1949US2017173151A1Human antibodies and antibody-drug conjugates against cd74GENMAB AS·Filed 2016·Application pending·0 cites
- 2048US2021177987A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2018·Application pending·0 cites
- 2145US2013004480A1CD20 Binding Molecules for the Treatment of CopdPARREN PAUL·Filed 2007·Application pending·0 cites
- 2237US2019233522A1New dosage regimens for antibody drug conjugates based on anti-axl antibodiesGENMAB AS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steen Lisby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →